AAPG Ascentage Pharma Group International
Healthcare$20.13-4.20%ClosedMarket Cap: $1.87B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
9.96
P/S
23.33
EV/EBITDA
-11.46
DCF Value
$-86.44
FCF Yield
-5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
84.1%
Operating Margin
-210.4%
Net Margin
-216.7%
ROE
-123.6%
ROA
-31.0%
ROIC
-33.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $334.1M | 79.4% | $-640.9M | $-640.0M | $— | — |
| FY null | $558.5M | 76.4% | $-1.18B | $-1.21B | $— | — |
| Q2 null | $233.7M | 90.7% | $-554.0M | $-590.8M | $— | — |
| Q4 null | $156.9M | 91.1% | $-566.8M | $-568.4M | $— | — |
| FY null | $980.6M | 97.0% | $-369.7M | $-405.4M | $— | — |
| Q2 null | $823.7M | 98.2% | $188.0M | $163.0M | $— | — |
| Q4 null | $79.3M | 84.4% | $-532.1M | $-523.3M | $— | — |
| FY null | $222.0M | 86.2% | $-872.6M | $-925.6M | $— | — |
| Q2 null | $142.7M | 87.3% | $-340.6M | $-402.4M | $— | — |
| Q4 null | $104.9M | 89.5% | $-424.9M | $-441.5M | $— | — |
| FY null | $209.7M | 89.5% | $-849.8M | $-882.9M | $— | — |
| Q2 null | $104.9M | 89.5% | $-424.9M | $-441.5M | $— | — |